Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Raymond James Downgrades Exact Sciences to Outperform, Lowers Price Target to $130

Raymond James analyst Andrew Cooper downgrades Exact Sciences (NASDAQ:EXAS) from Strong Buy to Outperform and lowers the price target from $160 to $130.

byBenzinga Newsdesk

November 3, 2021

1 minute read

Raymond James analyst Andrew Cooper downgrades Exact Sciences (NASDAQ:EXAS) from Strong Buy to Outperform and lowers the price target from $160 to $130.

Nuwellis Announces Pricing Of $9.6M Upsized Underwritten Public Offering

By Benzinga Newsdesk

Today, 5:20 AM

Nuwellis, Inc. (NASDAQ:NUWE) ("Nuwellis" or the "Company"), a commercial-stage company focused on transforming the lives of people with fluid overload, today announced the pricing of an underwritten

NUWE

News

American Airlines Says Data Breach Affected Small Number Of Customers; Hackers Gained Access To Personal Data For A “Very Small Number” Of Customers And Employees Through A Phishing Scam That Affected Some Employee Email Accounts – Wall Street Journal

By Benzinga Newsdesk

Today, 5:20 AM

- Dow Jones Citing WSJ

AAL

Raymond James Maintains Strong Buy on Apellis Pharmaceuticals, Lowers Price Target to $102

By Benzinga Newsdesk

Today, 5:20 AM

Raymond James analyst Steven Seedhouse maintains Apellis Pharmaceuticals (NASDAQ:APLS) with a Strong Buy and lowers the price target from $115 to $102.

APLS

Wells Fargo Maintains Underweight on FS KKR Capital, Lowers Price Target to $19

By Benzinga Newsdesk

Today, 5:20 AM

Wells Fargo analyst Finian O'Shea maintains FS KKR Capital (NYSE:FSK) with a Underweight and lowers the price target from $22 to $19.

FSK

Raymond James Downgrades Exact Sciences to Outperform, Lowers Price Target to $130

Related Posts

Nuwellis Announces Pricing Of $9.6M Upsized Underwritten Public Offering

American Airlines Says Data Breach Affected Small Number Of Customers; Hackers Gained Access To Personal Data For A “Very Small Number” Of Customers And Employees Through A Phishing Scam That Affected Some Employee Email Accounts – Wall Street Journal

Raymond James Maintains Strong Buy on Apellis Pharmaceuticals, Lowers Price Target to $102

Wells Fargo Maintains Underweight on FS KKR Capital, Lowers Price Target to $19